GRI Bio, Inc. Files Q1 2025 10-Q
Ticker: GRI · Form: 10-Q · Filed: May 15, 2025 · CIK: 1824293
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
GRI Bio (formerly Vallon Pharma) Q1 2025 10-Q filed. Financials updated.
AI Summary
GRI Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Vallon Pharmaceuticals, Inc., is focused on pharmaceutical preparations. The filing details financial information for the first quarter of 2025, including changes in common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides investors with an update on GRI Bio, Inc.'s financial health and capital structure as of the end of the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, GRI Bio faces inherent risks related to drug development, regulatory approvals, and market competition, which are not fully detailed in this summary financial filing.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the financial snapshot date.)
- 2025-05-15 — Filing Date (Shows when the report was submitted to the SEC.)
Key Players & Entities
- GRI Bio, Inc. (company) — Filer of the 10-Q
- Vallon Pharmaceuticals, Inc. (company) — Former name of GRI Bio, Inc.
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date
FAQ
What were the specific changes in GRI Bio, Inc.'s Additional Paid-In Capital during the first quarter of 2025?
The filing indicates that GRI Bio, Inc.'s Additional Paid-In Capital changed between January 1, 2025, and March 31, 2025, and also as of March 31, 2025, compared to December 31, 2024. Specific dollar amounts would be detailed within the full financial statements.
What is GRI Bio, Inc.'s primary business sector?
GRI Bio, Inc. operates in the Pharmaceutical Preparations sector, with the SIC code 2834.
When did GRI Bio, Inc. change its name from Vallon Pharmaceuticals, Inc.?
The company changed its name from Vallon Pharmaceuticals, Inc. on April 24, 2023.
What is the fiscal year-end for GRI Bio, Inc.?
GRI Bio, Inc.'s fiscal year ends on December 31.
What was the total number of documents filed as part of this 10-Q submission?
There were 58 public documents counted as part of this 10-Q submission.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding GRI Bio, Inc. (GRI).